MEDEZE Partners Establish GPO MEDEZE EMPOWER for ATMPs Development

MGR Online•Economy•8d ago

Reader Briefing

MEDEZE, GPO, and Cretan Associates form GPO MEDEZE EMPOWER to boost Thailand's Advanced Therapy Medicinal Products (ATMPs) sector.

•MEDEZE, the Government Pharmaceutical Organization (GPO), and Cretan Associates have signed an agreement to establish GPO MEDEZE EMPOWER.
•The new company will develop a factory for Cell Culture Media and ATMPs, aiming to reduce import dependency.
•This initiative seeks to position Thailand as a regional hub for Biopharma and Medical Innovation.

Overview

•MEDEZE Group, Government Pharmaceutical Organization (GPO), and Cretan Associates signed a memorandum of agreement to establish GPO MEDEZE EMPOWER.
•The initial registered capital for GPO MEDEZE EMPOWER is 105 million THB.
•The company will develop a factory for Cell Culture Media and Advanced Therapy Medicinal Products (ATMPs) adhering to GMP standards.
•The initiative aims to reduce reliance on imported raw materials from abroad and support the research and production of biopharmaceuticals.
•The goal is to drive Thailand towards becoming a regional center for ATMPs production and a Biopharma and Medical Innovation Hub for Asia.
•GPO MEDEZE EMPOWER also targets becoming a Contract Development and Manufacturing Organization (CDMO) for biopharmaceuticals.
•The venture aims to reduce the production and treatment costs of cell therapy by approximately 30-50%.
•The collaboration aims to enhance Thailand's capabilities from drug manufacturing to cutting-edge biotechnology and medical innovation.

Full article content is available on the original source.

Read on MGR Online (Thai Version)View in Google Translate

Source: MGR Online (Original)

View Original Article

Key Quotes

Dr. Somruedee Jong-suwan

"Thailand must not only be a user of foreign technology but must also be a creator of its own medical innovations."

ประเทศไทยต้องไม่เป็นเพียงผู้ใช้เทคโนโลยีจากต่างประเทศ แต่ต้องเป็นผู้สร้างนวัตกรรมการแพทย์ของตนเอง

Dr. Mingkwan Supanpong

"We believe that combining the strengths of the public and private sectors will help create a biotechnology ecosystem for the country, from development and production to actual utilization."

เราเชื่อว่าการผสานจุดแข็งของภาครัฐและภาคเอกชน จะช่วยสร้างระบบนิเวศด้าน Biotechnology ของประเทศ ตั้งแต่การพัฒนา การผลิต ไปจนถึงการนำไปใช้ประโยชน์จริง

Dr. Veerapon Keamarangsri

"MEDEZE is committed to developing knowledge, technology, personnel, and international standards to lay the foundation for cell technology and advanced medical treatments in Thailand."

MEDEZE มุ่งมั่นพัฒนาองค์ความรู้ เทคโนโลยี บุคลากร และมาตรฐานระดับสากล เพื่อวางรากฐานด้านเทคโนโลยีเซลล์และการแพทย์ขั้นสูงของประเทศไทย

Key Entities

Organization

MEDEZE

A Thai public company focused on developing cell and biological technologies, aiming to set international standards in advanced medical treatments.

Government Pharmaceutical Organization(องค์การเภสัชกรรม)ℹ️

A key Thai organization responsible for drug security and the national health system.

Cretan Associates(เครตาน แอสโซซิเอท)

A company specializing in investment and project development, part of Heracle Capital's investment in healthcare and longevity.

GPO MEDEZE EMPOWER(จีพีโอ เมดีซ เอ็มพาวเวอร์)

A newly established company formed by MEDEZE, GPO, and Cretan Associates to develop Cell Culture Media and ATMPs.

Heracle Capital

A Private Equity fund focused on healthcare and longevity, supporting Thai entrepreneurs for regional expansion.

Product

Cell Culture Media

A crucial raw material for the Advanced Therapy Medicinal Products (ATMPs) industry and a foundation for cell therapy and precision medicine.

Advanced Therapy Medicinal Products (ATMPs)

High-level medical treatments including cell therapy, gene therapy, and biotechnology that are transforming disease care globally.

Standard

GMPℹ️

Good Manufacturing Practice, a standard for the development and production of Cell Culture Media and ATMPs.

Person

Dr. Somruedee Jong-suwan(นายแพทย์สมฤกษ์ จึงสมาน)

The Permanent Secretary of the Ministry of Public Health, who officiated the signing ceremony.

Dr. Mingkwan Supanpong(แพทย์หญิงมิ่งขวัญ สุพรรณพงศ์)

Director of the Government Pharmaceutical Organization (GPO), emphasizing the GPO's mission in drug security and health system development.

Dr. Veerapon Keamarangsri(นายแพทย์วีรพล เขมะรังสรรค์)

Chief Executive Officer of MEDEZE Group, highlighting MEDEZE's commitment to developing cell and advanced medical technology.

Piyawat Rachpolasitou(นายปิยวัชร ราชพลสิทธิ์)

Chief Executive Officer of Cretan Associates, emphasizing Cretan's role in investing in and developing projects within the healthcare sector.

Concept

Medical Innovation Hub

A strategic goal for Thailand to become a leader in developing and owning medical technology and innovations.

Industry

Biopharmaℹ️

Biopharmaceutical industry, a key sector for developing advanced medical treatments and innovations.